4
Changes in Ownership
Contineum Therapeutics, Inc. Filed Acc 0001628280-26-045839
Options or other derivatives
- Director acquired 19,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Schimmelpennink Evert B. Director | 2026-06-26 | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | D | ||
Loading xslF345X06/wk-form4_1782510265.xml…